Synthesis and in vitro study of antiproliferative benzyloxy dihydropyrimidinones

Arch Pharm (Weinheim). 2021 Jun;354(6):e2000466. doi: 10.1002/ardp.202000466. Epub 2021 Feb 15.

Abstract

In this study, we report on antiproliferative benzyloxy dihydropyrimidinones (DHPMs) produced by the Biginelli reaction of benzyloxy benzaldehyde, urea, and diverse 1,3-diones. The reaction was catalyzed by lanthanum triflate and completed within 1-1.5 h, with 74-97% yield. The antiproliferative assay was carried out for all synthesized dihydropyrimidinones against six human solid tumor cell lines. Six compounds showed good antiproliferative activity with GI50 values below 5 μM. Among all the synthesized compounds, the most potent derivative showed good antiproliferative activity against all cell lines with GI50 values in the range of 1.1-3.1 μM. These DHPMs comply with druglikeness. Furthermore, ADMET prediction and the effect of P-glycoprotein on the antiproliferative activity were also studied. Overall, our method allows eco-friendly access to benzyloxy DHPMs as potential anticancer drugs.

Keywords: Lipinski's rule of five; antiproliferative activity; dihydropyrimidinones; lanthanum triflate.

MeSH terms

  • Antineoplastic Agents* / chemical synthesis
  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / pharmacology
  • Cell Line, Tumor
  • Cell Proliferation / drug effects*
  • Drug Screening Assays, Antitumor
  • Humans
  • Lanthanum / chemistry
  • Molecular Structure
  • Pyrimidinones* / chemical synthesis
  • Pyrimidinones* / chemistry
  • Pyrimidinones* / pharmacology
  • Structure-Activity Relationship
  • Urea / chemistry

Substances

  • Antineoplastic Agents
  • Pyrimidinones
  • Lanthanum
  • Urea